The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Live Last read · last published · next check
Bristol Myers Squibb (NYSE: BMY) announced it has selected Houston as the site for a new 600,000-square-foot multi-modal manufacturing campus, representing an approximately $2.3 billion investment. The campus, at Generation Park in Houston, will create nearly 500 skilled jobs, the company said. The campus’ multi-modal capabilities will allow BMS to manufacture multiple types of medicines – such…
Pharmaceutical manufacturing depends on repeatable inspection. A tablet with a crack, chip, stain, discoloration or other visible anomaly can signal a problem that deserves attention before product moves further downstream. Human inspection remains valuable, but it is inherently variable and difficult to scale consistently across long runs, multiple products and changing operators. Computer vision…
Codis announced today that it completed its previously announced acquisition of a UK-based manufacturing facility from Catalent. The Haverhill, England-based company agreed to acquire the oral solid dose (OSD) development and manufacturing plant in Nottingham last month. The facility adds OSD development and small-scale manufacturing capabilities to Codis’ offerings, enabling it to offer a single……
by Michael Irving, Xylem In pharmaceutical and biopharmaceutical manufacturing, there is zero margin for error when it comes to process integrity and operator safety. Among the many variables that must be tightly controlled, pressure ranks high on the list. Overpressure or vacuum conditions can compromise not only equipment, but also batch sterility, production timelines, and… The post Advancing…
Ratio Therapeutics announced today that it closed a $70 million Series C financing to support its radiopharmaceutical development and manufacturing. Existing investors Duquesne Family Office and Bristol Myers Squibb participated. New investors Catalio Capital Management, Eli Lilly and Wasatch Group joined as well. Boston-based Ratio plans to use the proceeds to fund its next phase… The post Ratio…
Resilience announced today that it expanded its strategic partnership with Eli Lilly (NYSE:LLY) to increase medicine production in the U.S. The Cincinnati-based CDMO and the pharmaceutical giant first struck a partnership in 2023. Now, with $750 million invested, the companies are expanding Resilience’s advanced pharmaceutical manufacturing operations in Ohio. Now, Resilience’s production in that…
Consider a common scenario: a pharmaceutical manufacturing plant has identified the equipment most critical to the success of its processes and has begun tracking overall equipment effectiveness (OEE) for those assets. Management has set an ambitious OEE metric of 95% for those critical machines, and operators and technicians are collaborating closely to make sure they… The post OEE is not a…
BeOne Medicines (Nasdaq:ONC) today announced the investment of $300 million to expand its U.S. manufacturing base. The expansion comes at the company’s flagship clinical and commercial-stage manufacturing and R&D center in Hopewell, New Jersey. It brings BeOne’s total U.S. manufacturing investment to more than $1 billion. BeOne said its latest expansion increases its production capacity… The post…
A Fujifilm Biotechnologies’ commercial-scale cell culture manufacturing facility has been selected for the FDA’s PreCheck Pilot Program, the company announced. The CDMO’s Holly Springs, North Carolina, facility was selected as one of seven participants in the program designed to strengthen United States pharmaceutical manufacturing capabilities and accelerate patient access to critical medicines.…
Otsuka ICU Medical today announced plans to invest more than $500 million to expand its U.S. IV solutions manufacturing in Texas. The companies (Otsuka Pharmaceutical Factory and ICU Medical), which launched this joint venture last year, plan to deliver a new facility and significant upgrades to its existing operations in Austin, Texas. They expect the… The post Otsuka ICU Medical to invest $500M…
